ReviewBioengineering (Basel, Switzerland)2026
Artificial Intelligence-Driven Reproductive Bioengineering: Integrating Fertility Diagnostics, Organ-on-Chip Systems, Cryobiology and Epigenetic Safety for Precision Reproductive Medicine.
Review in Bioengineering (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Traditional assisted reproductive technologies (ART) remain constrained by subjective, descriptive diagnostics and empirical, one-size-fits-all preservation strategies that expose gametes to nonphysiological stressors, risking disruptions to cellular homeostasis and epigenetic programming. This review explores the technological convergence of artificial intelligence (AI), reproductive organ-on-chip bioengineering, multiomics, and translational cryobiology and proposes an integrated, systems-level paradigm for next-generation precision reproductive medicine. By evaluating the clinical readiness, mechanistic insights, and translational trajectories of these emerging platforms, we show how AI architectures transition fertility diagnostics from descriptive metrics to predictive computational phenotyping by integrating high-dimensional imaging, multiomics, and sperm functional datasets. Concurrently, microphysiological platforms-such as testis-, ovary-, and endometrium-on-a-chip systems-recapitulate complex multicellular architecture and endocrine dynamics. When embedded with miniaturized biosensors and machine learning loops, these "smart" closed-loop microfluidic devices enable real-time biological monitoring and adaptive culture regulation. Furthermore, integrating AI analytics into cryobiology optimizes nonlinear thermodynamic variables, shifting the field from basic postthaw morphologic survival toward safeguarding macromolecular fidelity, mitochondrial competence, and long-term epigenetic safety across lifespans and generations. Ultimately, this computational-bioengineering roadmap transitions reproductive healthcare from a reactive discipline into a predictive, personalized, and adaptive framework. Overcoming persistent challenges in biological complexity, data interoperability, and multicenter clinical validation will lead to the establishment of safe, scalable, and ethically governed healthcare infrastructures capable of protecting developmental integrity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.